Related Experiment Video
Updated: Apr 6, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
[The TGF-β signaling pathway induced EMT in breast cancer]
Abstract:
Epithelial-mesenchymal transition (EMT) refers to tne transition during which epithelial cells undergo the loss of apical-basal polarity, acquisition of migration capability and transformation into mesenchymal cells. EMT induces breast cancer in situ to developing into metastasis and associates with the drug resistence. The multiple elements including signal pathways, transcriptional factors and downstream genes orchestrate the transition. Among them, the transforming growth factor β (TGF-β) signaling pathway plays a key role in the regulation of EMT in breast cancer. And this paper reviews the development of TGF-β signaling pathway induced EMT in breast cancer.
Insights
Epithelial-mesenchymal transition (EMT) drives breast cancer metastasis and drug resistance. This review details how the transforming growth factor beta (TGF-β) signaling pathway regulates EMT in breast cancer progression.
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- Epithelial-mesenchymal transition (EMT) is a cellular process crucial for embryonic development and wound healing.
- EMT involves the loss of epithelial characteristics and acquisition of mesenchymal traits, enabling cell migration.
- In breast cancer, EMT is linked to tumor progression, metastasis, and resistance to therapies.
Purpose of the Study:
- To review the role of the transforming growth factor beta (TGF-β) signaling pathway in inducing EMT.
- To explore the mechanisms by which TGF-β signaling drives EMT in breast cancer.
- To provide an overview of current understanding regarding TGF-β-induced EMT in breast cancer.
Main Methods:
- Literature review of scientific articles and research papers.
- Analysis of studies focusing on TGF-β signaling pathways and EMT.
- Synthesis of information on molecular players and regulatory networks involved.
Main Results:
- TGF-β signaling is a critical regulator of EMT in breast cancer.
- Activation of TGF-β pathway leads to molecular changes characteristic of EMT.
- EMT contributes significantly to the metastatic potential and therapeutic challenges in breast cancer.
Conclusions:
- The TGF-β signaling pathway is a key driver of EMT in breast cancer.
- Understanding TGF-β-induced EMT is vital for developing targeted anti-metastatic therapies.
- Further research into TGF-β signaling mechanisms can offer new therapeutic strategies for breast cancer.
Related Concept Videos
TGF - β Signaling Pathway
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Mitogens and the Cell Cycle
The Tumor Microenvironment
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...

